Valink Therapuetics is a startup based in the United Kingdom, most recent round Series A, 1 tracked investor.
Based in the United Kingdom, Valink Therapuetics is a startup founded in 2024. Its most recent tracked round is Series A. Brouky records 1 investor associated with the company.
Valink Therapeutics develops next-generation oncology therapeutics focusing on bispecific antibody-drug conjugates (bsADCs) to improve efficacy and safety in cancer treatment.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.